In a Form 8-K, Genzyme (Nasdaq: GENZ) reported preliminary Q4 sales of $1.08 billion, inline with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE